New hope for myeloma: donor transplant after initial success

This study looked at whether a stem cell transplant from a matched donor could help younger myeloma patients (under 65) who had already responded well to their first transplant. The goal was to improve how long patients lived without the disease getting worse. Patients received a reduced-intensity chemotherapy regimen before the donor transplant, followed by bortezomib if needed. The trial enrolled 13 participants and focused on survival rates and side effects like graft-versus-host disease.